Cumberland Pharmaceuticals Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $61.00K, a 75.19% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $10.44K, a 89.44% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for fiscal 2025 was $263.48K, a 54.50% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for fiscal 2024 was $579.05K, a 21.81% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for fiscal 2023 was $740.53K, a 29.68% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. payments for repurchase of common stock for fiscal 2022 was $1.05M, a 24.07% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $71.44K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $61.00K 10-Q · filed 2026-05-08 | $78.61K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $263.48K 10-K · filed 2026-03-09 |
| 2025-09-30 | $10.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $361.86K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $7.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $450.24K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $245.87K 10-Q · filed 2026-05-08 | $577.31K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $98.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $579.05K 10-K · filed 2026-03-09 |
| 2024-09-30 | $98.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $669.64K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $134.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $772.47K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $247.60K 10-Q · filed 2025-05-09 | $801.02K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $188.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $740.53K 10-K · filed 2025-03-07 |
| 2023-09-30 | $201.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $741.22K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $162.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $614.66K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $187.12K 10-Q · filed 2024-05-10 | $660.03K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $189.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.05M 10-K · filed 2024-03-13 |
| 2022-09-30 | $75.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.22M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $208.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.40M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $580.13K 10-Q · filed 2023-05-12 | $1.66M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $361.19K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $1.39M 10-K · filed 2023-03-13 |
| 2021-09-30 | $247.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.33M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $474.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.42M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $302.80K 10-Q · filed 2022-05-13 | $1.71M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $300.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.85M 10-K · filed 2022-03-11 |
| 2020-09-30 | $342.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.45M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | $766.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $3.48M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-03-31 | $442.54K 10-Q · filed 2021-05-14 | $3.22M derived: sum of 4 quarters · filed 2022-03-11 |
| 2019-12-31 | $901.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.49M 10-K · filed 2022-03-11 |
| 2019-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $3.09M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $507.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.15M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $712.92K 10-Q · filed 2020-05-22 | $2.58M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $496.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.88M 10-K · filed 2021-03-12 |
| 2018-09-30 | $431.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $3.21M derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-06-30 | $935.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $3.88M derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-03-31 | $1.02M 10-Q · filed 2019-05-15 | $4.19M derived: sum of 4 quarters · filed 2020-12-10 |
| 2017-12-31 | $830.52K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $3.72M 8-K · filed 2020-12-10 |
| 2017-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $3.54M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $2.62M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $545.92K 10-Q · filed 2018-05-09 | $2.09M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $641.32K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $2.52M 10-K · filed 2019-03-12 |
| 2016-09-30 | $190.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.55M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $709.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.67M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $979.29K 10-Q · filed 2017-05-15 | $4.61M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $669.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $5.34M 10-K · filed 2018-03-09 |
| 2015-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $6.25M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $6.09M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $1.71M 10-Q · filed 2016-05-13 | $5.11M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $4.32M 10-K · filed 2017-03-13 |
| 2014-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.62M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $660.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $3.22M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $919.58K 10-Q · filed 2015-05-15 | $3.78M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $882.47K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $4.80M 10-K · filed 2016-03-14 |
| 2013-09-30 | $756.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $5.18M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $7.69M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $1.94M 10-Q · filed 2014-05-12 | $7.68M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $8.09M 10-K · filed 2015-03-09 |
| 2012-09-30 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $8.19M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $6.26M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | $2.35M 10-Q · filed 2013-05-08 | $5.82M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $4.25M 10-K · filed 2014-03-11 |
| 2011-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $3.60M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $779.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $3.32M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $772.02K 10-Q · filed 2012-05-04 | |
| 2010-12-31 | $717.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $4.85M 10-K · filed 2013-03-12 |
| 2010-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | |
| 2009-12-31 | $27.30M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |